These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31702909)

  • 1. Fine Epitope Mapping of the CD19 Extracellular Domain Promotes Design.
    Klesmith JR; Wu L; Lobb RR; Rennert PD; Hackel BJ
    Biochemistry; 2019 Dec; 58(48):4869-4881. PubMed ID: 31702909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients.
    Laurent E; Sieber A; Salzer B; Wachernig A; Seigner J; Lehner M; Geyeregger R; Kratzer B; Jäger U; Kunert R; Pickl WF; Traxlmayr MW
    ACS Synth Biol; 2021 May; 10(5):1184-1198. PubMed ID: 33843201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins.
    Klesmith JR; Su L; Wu L; Schrack IA; Dufort FJ; Birt A; Ambrose C; Hackel BJ; Lobb RR; Rennert PD
    Mol Pharm; 2019 Aug; 16(8):3544-3558. PubMed ID: 31242389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of porcine CD19 and anti-CD19 monoclonal antibodies.
    Sun J; Sinkora J; Wertz N; Moravkova A; Butler JE
    Mol Immunol; 2004 Jul; 41(9):929-38. PubMed ID: 15261465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework.
    Kügler M; Stein C; Schwenkert M; Saul D; Vockentanz L; Huber T; Wetzel SK; Scholz O; Plückthun A; Honegger A; Fey GH
    Protein Eng Des Sel; 2009 Mar; 22(3):135-47. PubMed ID: 19188138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of B-cell co-receptor CD19 in complex with antibody B43 reveals an unexpected fold.
    Teplyakov A; Obmolova G; Luo J; Gilliland GL
    Proteins; 2018 May; 86(5):495-500. PubMed ID: 29490423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.
    Levy R; Forsyth CM; LaPorte SL; Geren IN; Smith LA; Marks JD
    J Mol Biol; 2007 Jan; 365(1):196-210. PubMed ID: 17059824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryo-EM structure of the B cell co-receptor CD19 bound to the tetraspanin CD81.
    Susa KJ; Rawson S; Kruse AC; Blacklow SC
    Science; 2021 Jan; 371(6526):300-305. PubMed ID: 33446559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Neutralising Nanobodies Bind to a Conserved Pocket in the Hemagglutinin Stem Region Identified Using Yeast Display and Deep Mutational Scanning.
    Gaiotto T; Hufton SE
    PLoS One; 2016; 11(10):e0164296. PubMed ID: 27741319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of variable N-glycosylation on the cytolytic potential of chimeric CD19 antibodies.
    Barbin K; Stieglmaier J; Saul D; Stieglmaier K; Stockmeyer B; Pfeiffer M; Lang P; Fey GH
    J Immunother; 2006; 29(2):122-33. PubMed ID: 16531813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic targeting of CD19 in hematological malignancies: past, present, future and beyond.
    Katz BZ; Herishanu Y
    Leuk Lymphoma; 2014 May; 55(5):999-1006. PubMed ID: 23885836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines.
    Schneider D; Xiong Y; Wu D; Nӧlle V; Schmitz S; Haso W; Kaiser A; Dropulic B; Orentas RJ
    J Immunother Cancer; 2017; 5():42. PubMed ID: 28515942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides.
    Coley AM; Campanale NV; Casey JL; Hodder AN; Crewther PE; Anders RF; Tilley LM; Foley M
    Protein Eng; 2001 Sep; 14(9):691-8. PubMed ID: 11707616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine epitope mapping of monoclonal antibody 5F1 reveals anticatalytic activity toward the N domain of human angiotensin-converting enzyme.
    Danilov SM; Watermeyer JM; Balyasnikova IV; Gordon K; Kugaevskaya EV; Elisseeva YE; Albrecht RF; Sturrock ED
    Biochemistry; 2007 Aug; 46(31):9019-31. PubMed ID: 17630779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopes.
    Sapra P; Allen TM
    Clin Cancer Res; 2004 Apr; 10(7):2530-7. PubMed ID: 15073133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal Antibody 2C6 Targets a Cross-Clade Conformational Epitope in gp41 with Highly Active Antibody-Dependent Cell Cytotoxicity.
    Sojar H; Baron S; Sullivan JT; Garrett M; van Haaren MM; Hoffman J; Overbaugh J; Doranz BJ; Hicar MD
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31217246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody deficiency due to a missense mutation in CD19 demonstrates the importance of the conserved tryptophan 41 in immunoglobulin superfamily domain formation.
    van Zelm MC; Smet J; van der Burg M; Ferster A; Le PQ; Schandené L; van Dongen JJ; Mascart F
    Hum Mol Genet; 2011 May; 20(9):1854-63. PubMed ID: 21330302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric, divalent and tetravalent anti-CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B-cell lymphoma and pre-B acute lymphoblastic leukemia cell lines.
    Liu XY; Pop LM; Tsai L; Pop IV; Vitetta ES
    Int J Cancer; 2011 Jul; 129(2):497-506. PubMed ID: 20878959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of linear epitopes recognized by monoclonal antibodies with gene-fragment phage display libraries.
    Petersen G; Song D; Hügle-Dörr B; Oldenburg I; Bautz EK
    Mol Gen Genet; 1995 Dec; 249(4):425-31. PubMed ID: 8552047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope mapping and structural analysis of an anti-ErbB2 antibody A21: Molecular basis for tumor inhibitory mechanism.
    Hu S; Zhu Z; Li L; Chang L; Li W; Cheng L; Teng M; Liu J
    Proteins; 2008 Feb; 70(3):938-49. PubMed ID: 17847085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.